The RNA analysis market was estimated to be worth USD 5.5 billion in 2023-e and is expected to reach USD 10.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.8 percent. Because of the growing use of cutting-edge technologies in genomics research and healthcare, the RNA analysis market offers encouraging prospects for growth, especially in emerging markets. These markets have a lot of room to grow because of their quick industrialization and changing regulatory environments.
Another noteworthy trend is the increasing use of RNA analysis in toxicogenomics applications. RNA sequencing is a useful technique for evaluating and comprehending the effects of environmental and chemical factors on biological systems because it can reveal patterns of gene expression in response to toxic substances. The need for RNA analysis technologies is anticipated to increase as toxicogenomics becomes more prominent in risk assessment and drug development, opening up a sizable market for businesses providing creative solutions in this vibrant and growing industry. The market for RNA analysis’s instrument segment comprises a range of tools and apparatus for RNA analysis. These tools are essential for streamlining the procedures involved in RNA analysis. The overall capabilities of RNA analysis are improved by the constant development of instruments that are more accurate, efficient, and user-friendly.
Health Technology Insights: 3Shape Unveils TRIOS 6 Scanner and TRIOS Dx Plus Software
Researchers can examine the expression levels of thousands of genes at once using microarrays in RNA analysis. The different kinds of microarray platforms and scanners used for gene expression profiling are covered in this section. Microarrays are used in many fields, such as disease pathway analysis, biomarker identification, and gene expression profiling. RNA analysis is used for diagnostic purposes in a clinical setting in the clinical diagnostics segment. This includes using RNA markers for disease detection and tracking. The creation of RNA analysis instruments appropriate for point-of-care settings improves clinical diagnostics’ speed and accessibility. This pattern helps RNA analysis become more widely used in standard medical procedures.
The hospitals & Diagnostic Centres segment involves the deployment of RNA analysis technologies in hospitals and diagnostic centres for various applications, including patient diagnosis, monitoring, and treatment planning. The integration of RNA analysis into hospitals and diagnostic centres reflects the clinical adoption of advanced molecular diagnostic technologies.
Asia Pacific is poised for substantial growth during the forecast period from 2024 to 2030. This surge can be attributed to the escalating focus on biomarker discovery and a heightened demand for transcriptomes in various research and development endeavors. Moreover, several countries in the APAC, including China, Japan, and South Korea, have made substantial investments in research and development in the life sciences and biotechnology sectors. Growing biotechnology and pharmaceutical industry in the region, and reliance of these sectors on RNA analysis for drug discovery, development, and personalized medicine is projected to fuel the market growth.
Health Technology Insights: Intelibly to Boost Patient Access via Zelis Dental Network
The RNA analysis market is characterized by the presence of various small and big players. The major market players include Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others. In a competitive market landscape, players are swiftly embracing advanced technologies to enhance RNA analysis market operations and bolster their competitive stance through strategic initiatives, including mergers, acquisitions, and the introduction of new products.
TRENDING REPORTS
- Healthcare Analytical Testing Services Market
- Healthcare ERP Market
- Healthcare Information Exchange Market
- Healthcare IT Outsourcing Market
- Health Intelligent Virtual Assistant Market
Health Technology Insights: TFS HealthScience Appoints Miriam Martin VP of Business Development
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
About Intent Market Research™
Intent Market Research (IMR) is a market research firm dedicated to providing unique, data-driven insights that support sustainable and inclusive business growth. We specialize in comprehensive market research reports and consulting services across diverse industries including chemicals, healthcare, automotive, energy, packaging, and semiconductor & electronics.
Our approach centers on delivering transformative market intelligence through syndicated reports, custom research, and strategic consulting services. We work closely with clients to develop tailored solutions that address unique business challenges, offering quantifiable market insights and forward-looking strategies. Our team of expert analysts and consultants combines cutting-edge competencies with a robust research methodology to help businesses explore new markets, develop innovative products, and uncover growth opportunities.
At IMR, we are committed to ethical standards and compliance, conducting research with transparency and integrity. We prioritize data privacy, maintain strict confidentiality, and adhere to industry regulations. Our goal is to empower businesses with comprehensive, fact-based insights that drive sustainable advantages and meaningful organizational change.
To find out more, visit Intent Market Research™ or follow us on LinkedIn.
Contact:
Mr. Jay Kumar
Intent Market Research
1846 E Innovation Park DR Site
100 ORO Valley
AZ 85755
USA: +1 463-583-2713
Email: sales@intentmarketsearch.com
